[
  {
    "ts": null,
    "headline": "Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio",
    "summary": "Exploring the Strategic Moves of a Seasoned Value Investor",
    "url": "https://finnhub.io/api/news?id=f5173688bc4535e5e1164096c0300f085d6a92a8cbd4345c63ef120b70a1cf69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771023688,
      "headline": "Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio",
      "id": 139091179,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Exploring the Strategic Moves of a Seasoned Value Investor",
      "url": "https://finnhub.io/api/news?id=f5173688bc4535e5e1164096c0300f085d6a92a8cbd4345c63ef120b70a1cf69"
    }
  },
  {
    "ts": null,
    "headline": "SNY Stock Falls After Board Suddenly Makes Leadership Change",
    "summary": "Sanofi stock slides 4.5% after it decides not to renew CEO Paul Hudson's mandate and names Belen Garijo as successor amid investor skepticism.",
    "url": "https://finnhub.io/api/news?id=5142263ab9007ba912266ff36b0e1b1b1d056626181a992bac3d609305b6a1d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771005300,
      "headline": "SNY Stock Falls After Board Suddenly Makes Leadership Change",
      "id": 139088093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Sanofi stock slides 4.5% after it decides not to renew CEO Paul Hudson's mandate and names Belen Garijo as successor amid investor skepticism.",
      "url": "https://finnhub.io/api/news?id=5142263ab9007ba912266ff36b0e1b1b1d056626181a992bac3d609305b6a1d8"
    }
  },
  {
    "ts": null,
    "headline": "Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer",
    "summary": "If you are wondering whether Exact Sciences at around US$103 a share still offers value, you are not alone. This article is all about putting that price tag into context. The stock has returned 0.6% over the last 7 days, 1.0% over 30 days, 1.5% year to date and 104.1% over the past year, while the 3 year return sits at 61.9% and the 5 year return at a 27.1% decline. Recently, headlines have focused on Exact Sciences as a key player in cancer screening and diagnostics, with media coverage...",
    "url": "https://finnhub.io/api/news?id=ba9f158f63298a1074b7dfed47fde41177032039dcde282d9b923961aa9845ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770981318,
      "headline": "Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer",
      "id": 139079769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "If you are wondering whether Exact Sciences at around US$103 a share still offers value, you are not alone. This article is all about putting that price tag into context. The stock has returned 0.6% over the last 7 days, 1.0% over 30 days, 1.5% year to date and 104.1% over the past year, while the 3 year return sits at 61.9% and the 5 year return at a 27.1% decline. Recently, headlines have focused on Exact Sciences as a key player in cancer screening and diagnostics, with media coverage...",
      "url": "https://finnhub.io/api/news?id=ba9f158f63298a1074b7dfed47fde41177032039dcde282d9b923961aa9845ff"
    }
  },
  {
    "ts": null,
    "headline": "1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky",
    "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
    "url": "https://finnhub.io/api/news?id=5c2af7ea3acb13abd5b61833ba5511d79854bb7456b76f5aa18e72205a0b4df6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770957715,
      "headline": "1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky",
      "id": 139089725,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
      "url": "https://finnhub.io/api/news?id=5c2af7ea3acb13abd5b61833ba5511d79854bb7456b76f5aa18e72205a0b4df6"
    }
  }
]